Michael DiTolla - Jun 11, 2021 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role: Director
Signature: /s/ Michael C. Carroll, attorney-in-fact for Michael DiTolla
Stock symbol: BIOL
Transactions as of: Jun 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/14/2021, 09:10 PM
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOL	Stock Appreciation Right	Award	$0	+105K		$0.00	105K	Jun 11, 2021	Common Stock	105K	$0.84	Direct	F1
transaction	BIOL	Restricted Stock Unit	Award	$0	+110K		$0.00	110K	Jun 11, 2021	Common Stock	110K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Of the stock appreciation rights subject to this SAR, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant.
F2	At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F3	The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.